Month: February 2019

Vivacelle Bio, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threatening conditions due to blood loss and other causes of severe hypovolemia (low blood volume).

     Leaders are shaped by several things, most especially the people around them as they move from childhood to adulthood.  The values we are given, the character we see modeled and the principles we are told to live by.   These things become anchors of our lives.

Thirty years ago, a diagnosis of HIV or AIDS was a death sentence for many. As the years have gone by, though, advances have been made in the area of treatment and People Living With HIV (PLWH) are living longer

In advance of its 27th annual African-American Achievers awards ceremony, JM Family Enterprises, Southeast Toyota Distributors and JM Lexus recently held a private reception to announce the 2019 African American Achievers.